Healthcare specialists optimistic on IBM's AI tech  

The delayed progress of IBM Watson, a cognitive technology that enables healthcare professionals to access unstructured and previously unobtainable medical data, demonstrates the 'slow process of commercializing new technology', claims The New York Times. Despite this, Watson has received substantial investment over the past five years as a form of AI technology and specialists are optimistic concerning its development and integration into the industry.

When IBM’s Watson computer triumphed over human champions in the quiz show “Jeopardy!” it was a stunning achievement that suggested limitless horizons for artificial intelligence.

Soon after, IBM’s leaders moved to convert Watson from a celebrated science project into a moneymaking business, starting with health care.

Yet the next few years after its game show win proved humbling for Watson. Today, IBM executives candidly admit that medicine proved far more difficult than they anticipated. Costs and frustration mounted on Watson’s early projects. They were scaled back, refocused and occasionally shelved.

IBM’s early struggles with Watson point to the sobering fact that commercializing new technology, however promising, typically comes in short steps rather than giant leaps.